2022 Q1 Form 10-Q Financial Statement
#000175353922000031 Filed on May 11, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
Revenue | $13.90M | $0.00 |
YoY Change | ||
Cost Of Revenue | $10.96M | $5.510M |
YoY Change | 98.82% | |
Gross Profit | $2.941M | $1.790M |
YoY Change | 64.3% | |
Gross Profit Margin | 21.16% | |
Selling, General & Admin | $22.54M | $8.478M |
YoY Change | 165.82% | |
% of Gross Profit | 766.27% | 473.63% |
Research & Development | $146.0K | $28.00K |
YoY Change | 421.43% | |
% of Gross Profit | 4.96% | 1.56% |
Depreciation & Amortization | $7.391M | $2.764M |
YoY Change | 167.4% | |
% of Gross Profit | 251.31% | 154.41% |
Operating Expenses | $22.68M | $8.506M |
YoY Change | 166.66% | |
Operating Profit | -$27.13M | -$9.485M |
YoY Change | 186.05% | 3571.72% |
Interest Expense | $1.255M | $1.168M |
YoY Change | 7.45% | |
% of Operating Profit | ||
Other Income/Expense, Net | $2.000K | -$10.67M |
YoY Change | -100.02% | -252.86% |
Pretax Income | -$19.99M | -$168.6M |
YoY Change | -88.14% | -2607.79% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$19.99M | -$168.6M |
YoY Change | -88.14% | -2716.33% |
Net Earnings / Revenue | -143.84% | |
Basic Earnings Per Share | -$0.17 | -$0.70 |
Diluted Earnings Per Share | -$0.17 | -$0.70 |
COMMON SHARES | ||
Basic Shares Outstanding | 115.5M shares | 242.3M shares |
Diluted Shares Outstanding | 115.5M shares | 242.3M shares |
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $135.9M | $171.2K |
YoY Change | 79268.03% | |
Cash & Equivalents | $135.9M | $44.79M |
Short-Term Investments | ||
Other Short-Term Assets | $7.562M | $319.5K |
YoY Change | 2266.6% | |
Inventory | ||
Prepaid Expenses | $64.17K | |
Receivables | $5.491M | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $151.8M | $490.7K |
YoY Change | 30833.76% | -55.0% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $67.10M | |
YoY Change | ||
Goodwill | $9.393M | |
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $4.259M | $318.1M |
YoY Change | -98.66% | |
Other Assets | $565.0K | |
YoY Change | ||
Total Long-Term Assets | $135.5M | $318.1M |
YoY Change | -57.4% | -0.12% |
TOTAL ASSETS | ||
Total Short-Term Assets | $151.8M | $490.7K |
Total Long-Term Assets | $135.5M | $318.1M |
Total Assets | $287.3M | $318.5M |
YoY Change | -9.81% | -0.31% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $15.53M | $4.065M |
YoY Change | 282.04% | |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | $9.528M | |
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $31.63M | $4.065M |
YoY Change | 678.06% | 863.95% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $71.91M | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $1.463M | $57.52M |
YoY Change | -97.46% | |
Total Long-Term Liabilities | $73.37M | $57.52M |
YoY Change | 27.55% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $31.63M | $4.065M |
Total Long-Term Liabilities | $73.37M | $57.52M |
Total Liabilities | $120.4M | $61.59M |
YoY Change | 95.51% | 432.31% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$490.9M | -$61.30M |
YoY Change | 700.78% | -4486.05% |
Common Stock | $12.00K | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $166.9M | -$95.63M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $287.3M | $318.5M |
YoY Change | -9.81% | -0.31% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$19.99M | -$168.6M |
YoY Change | -88.14% | -2716.33% |
Depreciation, Depletion And Amortization | $7.391M | $2.764M |
YoY Change | 167.4% | |
Cash From Operating Activities | -$12.68M | -$10.58M |
YoY Change | 19.78% | 2994.24% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$1.926M | $20.00K |
YoY Change | -9730.0% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$11.50M | $40.05K |
YoY Change | -28811.61% | |
Cash From Investing Activities | -$13.43M | -$7.519M |
YoY Change | 78.55% | -6616.05% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -$3.599M | $57.79M |
YoY Change | -106.23% | |
NET CHANGE | ||
Cash From Operating Activities | -$12.68M | -$10.58M |
Cash From Investing Activities | -$13.43M | -$7.519M |
Cash From Financing Activities | -$3.599M | $57.79M |
Net Change In Cash | -$29.70M | $39.69M |
YoY Change | -174.83% | -17612.61% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$12.68M | -$10.58M |
Capital Expenditures | -$1.926M | $20.00K |
Free Cash Flow | -$10.75M | -$10.60M |
YoY Change | 1.39% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001753539 | |
CY2022Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2022Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P9M | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
||
CY2022Q1 | bksy |
Earn Out Shares Expiration Term
EarnOutSharesExpirationTerm
|
P7Y | |
CY2022Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2022Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2022Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-03-31 | |
CY2022Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022Q1 | dei |
Entity File Number
EntityFileNumber
|
001-39113 | |
CY2022Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
BLACKSKY TECHNOLOGY INC | |
CY2022Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
47-1949578 | |
CY2022Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
13241 Woodland Park Road | |
CY2022Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 300 | |
CY2022Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Herndon | |
CY2022Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | |
CY2022Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20171 | |
CY2022Q1 | dei |
City Area Code
CityAreaCode
|
571 | |
CY2022Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
267-1571 | |
CY2022Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
120575011 | shares |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
135886000 | USD |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
165586000 | USD |
CY2022Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
2518000 | USD |
CY2021Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
2518000 | USD |
CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
8000 | USD |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
39000 | USD |
CY2022Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5491000 | USD |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2629000 | USD |
CY2022Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5044000 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
6264000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
2865000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
1678000 | USD |
CY2022Q1 | us-gaap |
Assets Current
AssetsCurrent
|
151804000 | USD |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
178675000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
67102000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
70551000 | USD |
CY2022Q1 | us-gaap |
Goodwill
Goodwill
|
9393000 | USD |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
9393000 | USD |
CY2022Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
4259000 | USD |
CY2021Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
4002000 | USD |
CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2339000 | USD |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2480000 | USD |
CY2022Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
51846000 | USD |
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
40102000 | USD |
CY2022Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
565000 | USD |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
560000 | USD |
CY2022Q1 | us-gaap |
Assets
Assets
|
287308000 | USD |
CY2021Q4 | us-gaap |
Assets
Assets
|
305763000 | USD |
CY2022Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
15530000 | USD |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
10837000 | USD |
CY2022Q1 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
3951000 | USD |
CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
5613000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
9528000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
11266000 | USD |
CY2022Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2619000 | USD |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2819000 | USD |
CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
31628000 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
30535000 | USD |
CY2022Q1 | bksy |
Liability For Estimated Contract Losses
LiabilityForEstimatedContractLosses
|
3626000 | USD |
CY2021Q4 | bksy |
Liability For Estimated Contract Losses
LiabilityForEstimatedContractLosses
|
6054000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
3000000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
568000 | USD |
CY2022Q1 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
8786000 | USD |
CY2021Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
16925000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
71909000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
71408000 | USD |
CY2022Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1463000 | USD |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
653000 | USD |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
120412000 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
126143000 | USD |
CY2022Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120506000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
117160000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
117927000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
114452000 | shares |
CY2022Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
12000 | USD |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
11000 | USD |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
657781000 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
650518000 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-490897000 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-470909000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
166896000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
179620000 | USD |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
287308000 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
305763000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
13896000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7294000 | USD |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
22536000 | USD |
CY2021Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8478000 | USD |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
146000 | USD |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
28000 | USD |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
7391000 | USD |
CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2764000 | USD |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27132000 | USD |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9485000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
8140000 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-14008000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
257000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
196000 | USD |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
1255000 | USD |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
1168000 | USD |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-144091000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-168556000 | USD |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-168556000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1389000 | USD |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-167167000 | USD |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
115479000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
242289000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
115479000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
242289000 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
179620000 | USD |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
10862000 | USD |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
17000 | USD |
CY2022Q1 | bksy |
Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures
|
1000 | USD |
CY2022Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
3616000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19988000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
166896000 | USD |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
508000 | USD |
CY2022Q1 | bksy |
Stock Issued During Period Value Bridge Financing
StockIssuedDuringPeriodValueBridgeFinancing
|
103724000 | USD |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1389000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-168556000 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-95627000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-168556000 | USD |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7391000 | USD |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2764000 | USD |
CY2022Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
6000 | USD |
CY2021Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
10240000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
508000 | USD |
CY2022Q1 | bksy |
Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
|
0 | USD |
CY2021Q1 | bksy |
Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
|
-96476000 | USD |
CY2022Q1 | bksy |
Debt Issuance Cost Expensed For Debt Carried At Fair Value
DebtIssuanceCostExpensedForDebtCarriedAtFairValue
|
0 | USD |
CY2021Q1 | bksy |
Debt Issuance Cost Expensed For Debt Carried At Fair Value
DebtIssuanceCostExpensedForDebtCarriedAtFairValue
|
47623000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
502000 | USD |
CY2021Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
348000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
257000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
196000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-24000 | USD |
CY2022Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
8140000 | USD |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-14008000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2868000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1651000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
1187000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
66000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-1220000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
158000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
5000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-96000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1533000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3753000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-200000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-11000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
694000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
1258000 | USD |
CY2022Q1 | bksy |
Increase Decrease In Liability For Estimated Contract Losses
IncreaseDecreaseInLiabilityForEstimatedContractLosses
|
-2428000 | USD |
CY2021Q1 | bksy |
Increase Decrease In Liability For Estimated Contract Losses
IncreaseDecreaseInLiabilityForEstimatedContractLosses
|
-171000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
811000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
874000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12676000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10583000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
1926000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
17000 | USD |
CY2022Q1 | bksy |
Satellite Procurement Work In Process
SatelliteProcurementWorkInProcess
|
11499000 | USD |
CY2021Q1 | bksy |
Satellite Procurement Work In Process
SatelliteProcurementWorkInProcess
|
7502000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-13425000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7519000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | USD |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
58082000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
17000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
CY2021Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
120000 | USD |
CY2022Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2021Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
321000 | USD |
CY2022Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2021Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
91000 | USD |
CY2022Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
3616000 | USD |
CY2021Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3599000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
57791000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-29700000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
39689000 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
168104000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10573000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138404000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
50262000 | USD |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
135886000 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
44787000 | USD |
CY2022Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
2518000 | USD |
CY2021Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
5475000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138404000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
50262000 | USD |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
129000 | USD |
CY2022Q1 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
0 | USD |
CY2021Q1 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
3588000 | USD |
CY2022Q1 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
0 | USD |
CY2021Q1 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
135000 | USD |
CY2022Q1 | bksy |
Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
|
622000 | USD |
CY2021Q1 | bksy |
Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
|
0 | USD |
CY2022Q1 | bksy |
Issuance Of Common Stock Due To Bridge Notes And Rights Offering Net Of Issuance
IssuanceOfCommonStockDueToBridgeNotesAndRightsOfferingNetOfIssuance
|
0 | USD |
CY2021Q1 | bksy |
Issuance Of Common Stock Due To Bridge Notes And Rights Offering Net Of Issuance
IssuanceOfCommonStockDueToBridgeNotesAndRightsOfferingNetOfIssuance
|
103724000 | USD |
CY2022Q1 | bksy |
Issuance Of Common Stock Warrants Due To Bridge Financing
IssuanceOfCommonStockWarrantsDueToBridgeFinancing
|
0 | USD |
CY2021Q1 | bksy |
Issuance Of Common Stock Warrants Due To Bridge Financing
IssuanceOfCommonStockWarrantsDueToBridgeFinancing
|
18373000 | USD |
CY2022Q1 | bksy |
Consent Fees Payable
ConsentFeesPayable
|
0 | USD |
CY2021Q1 | bksy |
Consent Fees Payable
ConsentFeesPayable
|
2715000 | USD |
CY2022Q1 | bksy |
Number Of Satellites
NumberOfSatellites
|
12 | satellite |
CY2022Q1 | bksy |
Number Of Subsidiaries
NumberOfSubsidiaries
|
2 | subsidiary |
CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingencies at the reporting date, and the reported amounts of revenue and expenses during the reporting period. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Actual results could materially differ from these estimates. Significant estimates made by the Company relate to revenue and associated cost recognition, the collectability of accounts receivable, the recoverability and useful lives of property and equipment, the valuation of equity warrants and warrant liabilities, fair value estimates, the recoverability of goodwill and intangible assets, the provision for income taxes, and stock-based compensation.</span></div> | |
CY2022Q1 | bksy |
Revenue Performance Obligation Satisfied Over Time Change In Estimate Increase Decrease In Cost To Cost
RevenuePerformanceObligationSatisfiedOverTimeChangeInEstimateIncreaseDecreaseInCostToCost
|
1200000 | USD |
CY2022Q1 | bksy |
Revenue Performance Obligation Satisfied Over Time Change In Estimate Number Of Contracts
RevenuePerformanceObligationSatisfiedOverTimeChangeInEstimateNumberOfContracts
|
2 | contract |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
13896000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7294000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
13896000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7294000 | USD |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
13896000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7294000 | USD |
CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
8000 | USD |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
39000 | USD |
CY2022Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5491000 | USD |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2629000 | USD |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
24700000 | USD |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
20100000 | USD |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
4400000 | USD |
CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
200000 | USD |
CY2022Q1 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
2436000 | USD |
CY2021Q4 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
788000 | USD |
CY2022Q1 | bksy |
Other Contract With Customer Asset After Allowance For Credit Loss Current
OtherContractWithCustomerAssetAfterAllowanceForCreditLossCurrent
|
429000 | USD |
CY2021Q4 | bksy |
Other Contract With Customer Asset After Allowance For Credit Loss Current
OtherContractWithCustomerAssetAfterAllowanceForCreditLossCurrent
|
890000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
2865000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
1678000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
9528000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
11266000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
3000000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
568000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
3000000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
568000 | USD |
CY2022Q1 | bksy |
Contract With Customer Asset Changes Of Contract Costs
ContractWithCustomerAssetChangesOfContractCosts
|
460000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
1678000 | USD |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
11834000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
|
589000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
|
7735000 | USD |
CY2022Q1 | bksy |
Contract With Customer Liability Payments Received
ContractWithCustomerLiabilityPaymentsReceived
|
6746000 | USD |
CY2022Q1 | bksy |
Contract With Customer Asset Changes In Contract Assets Net
ContractWithCustomerAssetChangesInContractAssetsNet
|
1058000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
|
0 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
|
1335000 | USD |
CY2022Q1 | bksy |
Contract With Customer Liability Cumulative Catch Up Adjustment Arising From Contract Modification
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentArisingFromContractModification
|
290000 | USD |
CY2022Q1 | bksy |
Contract With Customer Liability Changes Of Contract Costs
ContractWithCustomerLiabilityChangesOfContractCosts
|
0 | USD |
CY2022Q1 | bksy |
Contract With Customer Liability Changes Of Contract Liabilities
ContractWithCustomerLiabilityChangesOfContractLiabilities
|
-58000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
2865000 | USD |
CY2022Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
12528000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
101776000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
98011000 | USD |
CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
34674000 | USD |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
27460000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
67102000 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
70551000 | USD |
CY2022Q1 | us-gaap |
Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
|
36000 | USD |
CY2021Q1 | us-gaap |
Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
|
700000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-24000 | USD |
CY2022Q1 | bksy |
Long Term Debt Gross Current
LongTermDebtGrossCurrent
|
0 | USD |
CY2021Q4 | bksy |
Long Term Debt Gross Current
LongTermDebtGrossCurrent
|
0 | USD |
CY2022Q1 | bksy |
Long Term Debt Gross Noncurrent
LongTermDebtGrossNoncurrent
|
74126000 | USD |
CY2021Q4 | bksy |
Long Term Debt Gross Noncurrent
LongTermDebtGrossNoncurrent
|
74126000 | USD |
CY2022Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
74126000 | USD |
CY2021Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
74126000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
76100000 | USD |
CY2022Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
2217000 | USD |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
2718000 | USD |
CY2022Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
71909000 | USD |
CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
71408000 | USD |
CY2021Q1 | bksy |
Debt Instrument Number Of Tranches
DebtInstrumentNumberOfTranches
|
2 | tranche |
CY2021Q2 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
58600000 | USD |
CY2022Q1 | bksy |
Debt Instrument Number Of Tranches
DebtInstrumentNumberOfTranches
|
3 | tranche |
CY2022Q1 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
20343000 | shares |
CY2022Q1 | us-gaap |
Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
|
3924000 | shares |
CY2022Q1 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
71400000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | USD |
CY2021Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
47623000 | USD |
CY2022Q1 | bksy |
Other Income Expense
OtherIncomeExpense
|
2000 | USD |
CY2021Q1 | bksy |
Other Income Expense
OtherIncomeExpense
|
8000 | USD |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-144091000 | USD |
CY2021Q1 | bksy |
Debt Instrument Number Of Tranches
DebtInstrumentNumberOfTranches
|
2 | tranche |
CY2021Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
47600000 | USD |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120500000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
117900000 | shares |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
|
2400000 | shares |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Term Of Shares
DerivativeInstrumentContingentConsiderationLiabilityTermOfShares
|
P7Y | |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Shares With Release Provision Terms Volume Weighted Average Price Per Share
DerivativeInstrumentContingentConsiderationLiabilitySharesWithReleaseProvisionTermsVolumeWeightedAveragePricePerShare
|
15.00 | |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Shares With Release Provision Terms Number Of Trading Days
DerivativeInstrumentContingentConsiderationLiabilitySharesWithReleaseProvisionTermsNumberOfTradingDays
|
10 | tradingDay |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Shares With Release Provision Terms Earnout Period Threshold Consecutive Trading Days
DerivativeInstrumentContingentConsiderationLiabilitySharesWithReleaseProvisionTermsEarnoutPeriodThresholdConsecutiveTradingDays
|
20 | tradingDay |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Shares Volume Weighted Average Price Per Share
DerivativeInstrumentContingentConsiderationLiabilitySharesVolumeWeightedAveragePricePerShare
|
17.50 | |
CY2022Q1 | bksy |
Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Consecutive Trading Days
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdConsecutiveTradingDays
|
20 | satellite |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-168556000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
CY2021Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19988000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-168556000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.17 | |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.17 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.70 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.70 | |
CY2022Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0 | |
CY2022Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0 | |
CY2021Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0 | |
CY2021Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
115479000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
115479000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
242289000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
242289000 | shares |
CY2022Q1 | bksy |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
|
2 | plan |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P4Y | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
10240000 | USD |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
508000 | USD |
CY2022Q1 | bksy |
Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
|
600000 | USD |
CY2021Q1 | bksy |
Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
|
0 | USD |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5022000 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.4914 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
404000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.0437 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
11000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.0121 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4607000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.8917 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y7M9D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
2975000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1063000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.4854 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y9M14D | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1515000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1200000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
2700000 | USD |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
200000 | USD |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
200000 | USD |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
3800000 | USD |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y6M | |
CY2022Q1 | bksy |
Interest Payable Related Parties
InterestPayableRelatedParties
|
1200000 | USD |
CY2021Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
737000 | USD |
CY2022Q1 | bksy |
Payments For Liability For Uncertainty In Income Taxes
PaymentsForLiabilityForUncertaintyInIncomeTaxes
|
0 | USD |
CY2022Q1 | bksy |
Liability For Uncertainty In Income Taxes Noncurrent Adjustment To Expense
LiabilityForUncertaintyInIncomeTaxesNoncurrentAdjustmentToExpense
|
0 | USD |
CY2022Q1 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
737000 | USD |
CY2022Q1 | bksy |
Long Term Purchase Commitment Number Of Launches
LongTermPurchaseCommitmentNumberOfLaunches
|
2 | satelliteLaunch |
CY2022Q1 | bksy |
Long Term Purchase Commitment Number Of Satellites
LongTermPurchaseCommitmentNumberOfSatellites
|
4 | satellite |
CY2022Q1 | bksy |
Long Term Purchase Commitment Launch Delay Period
LongTermPurchaseCommitmentLaunchDelayPeriod
|
P365D | |
CY2022Q1 | bksy |
Long Term Purchase Commitment Remanifest Effort Period
LongTermPurchaseCommitmentRemanifestEffortPeriod
|
P4M | |
CY2022Q1 | bksy |
Long Term Purchase Commitment Launch Delay Period
LongTermPurchaseCommitmentLaunchDelayPeriod
|
P365D | |
CY2022Q1 | bksy |
Long Term Purchase Commitment Payment Period After Invoice Date
LongTermPurchaseCommitmentPaymentPeriodAfterInvoiceDate
|
P15D |